AMY MOORE: Open Payments
NPI 1831731769 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,878 in 15 payments from 9 companies in 2025. Trend: 2023 $301 · 2024 $587 · 2025 $4,878
Consulting: $4,000Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Pulmonx Corporation | 6 | $4,462 |
| United Therapeutics Corporation | 1 | $128 |
| Pharming Healthcare, Inc. | 1 | $107 |
| Astellas Pharma US Inc | 2 | $51 |
| Insmed, Inc. | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Verona Pharma, Inc. | 1 | $30 |
| Genentech USA, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: ZEPHYR ENDOBRONCHIAL VALVE, CHARTIS CATHETER, Cresemba, Arikayce, OPSYNVI, Ohtuvayre, Xolair, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
